After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Akoya Biosciences Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Medical Instruments & Supplies industry. The current market capitalization of Akoya Biosciences Inc is $145.22M. A total of 1.05 million shares were traded on the day, compared to an average of 551.09K shares.
In the most recent transaction, McKelligon Brian sold 7,500 shares of AKYA for 2.08 per share on Jun 11 ’24. After the transaction, the President and CEO now owns 224,733 company shares. In a previous transaction on Jun 06 ’24, McKelligon Brian sold 7,500 shares at 2.01 per share. AKYA shares that President and CEO owns now total 224,733.
Among the insiders who sold shares, McKelligon Brian disposed of 7,500 shares on Mar 20 ’24 at a per-share price of $4.97. This resulted in the President and CEO holding 231,868 shares of AKYA after the transaction. In another insider transaction, McKelligon Brian sold 7,500 shares at $4.94 per share on Mar 13 ’24. Company shares held by the President and CEO now total 224,368.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, AKYA has a high of $6.31 and a low of $1.88.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. AKYA’s latest balance sheet shows that the firm has $113.08M in Cash & Short Term Investments as of fiscal 2021. There were $32.94M in debt and $27.68M in liabilities at the time. Its Book Value Per Share was $0.28, while its Total Shareholder’s Equity was $121.35M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AKYA is Buy with a score of 3.75.
